Skip to main content
Edward Hsiao, MD, Endocrinology, San Francisco, CA

Edward C. Hsiao MD

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine


Assistant Professor in Residence, Internal Medicine, UCSF School of Medicine

Join to View Full Profile
  • 4150 Clement St# 111NSan Francisco, CA 94121

  • Phone+1 415-750-2089

Dr. Hsiao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2009
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2001 - 2004
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2025
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Vitamin D Won’t Prevent Falls, Fractures in Older Adults. Here's What Will Help
    Vitamin D Won’t Prevent Falls, Fractures in Older Adults. Here's What Will HelpDecember 19th, 2024
  • Clementia Initiates Pivotal Phase 3 MOVE Trial for Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva
    Clementia Initiates Pivotal Phase 3 MOVE Trial for Palovarotene in Patients with Fibrodysplasia Ossificans ProgressivaDecember 12th, 2017
  • Organovo and UCSF Partner to Create 3D Bioprinted Tissues for Skeletal Disease Research
    Organovo and UCSF Partner to Create 3D Bioprinted Tissues for Skeletal Disease ResearchJune 14th, 2016
  • Join now to see all

Grant Support

  • An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans ProgressivaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2028
  • An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans ProgressivaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2028
  • An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans ProgressivaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2028
  • Novel Strategies for Understanding and Treating Fibrous DysplasiaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
  • Novel Strategies for Understanding and Treating Fibrous DysplasiaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2027
  • Novel Strategies for Understanding and Treating Fibrous DysplasiaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2027
  • Novel Strategies for Understanding and Treating Fibrous DysplasiaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2027
  • the Gut Microbiome as a Disease Modifier of Heterotopic OssificationEMORY UNIVERSITY2022–2027
  • the Gut Microbiome as a Disease Modifier of Heterotopic OssificationEMORY UNIVERSITY2022–2027
  • Diabetes, Endocrinology & Metabolism Training GrantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO1981–2027
  • Diabetes, Endocrinology & Metabolism Training GrantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO1981–2027
  • Diabetes, Endocrinology & Metabolism Training GrantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO1981–2027
  • Diabetes, Endocrinology & Metabolism Training GrantUNIVERSITY OF CALIFORNIA, SAN FRANCISCO1981–2027

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: